Capital Advisory Group Advisory Services, LLC Cassava Sciences Inc Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$36.77 - $90.91 $4,596 - $11,363	-125 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$41.79 - $135.3 $5,223 - $16,912	125 New	125 $8,000

Others Institutions Holding SAVA

# of Institutions

195

Shares Held

13.7M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$8.11 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$6.36 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$2.93 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.54 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.46 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account